Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Reiteration

Reiteration

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • General
  • Health Care
  • News
  • Penny Stocks
  • Price Target
  • Reiteration

This Analyst Cuts ChromaDex’s Price Target On Revised Growth Trajectory

By Vandana Singh
August 29, 3:07 PM
Earlier this month, ChromaDex Corp (NASDAQ:CDXC) released Q2 earnings, indicating high single-digit revenue growth for FY22, driven by its global e-commerce…

CDXC

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • News
  • Price Target
  • Reiteration
  • Small Cap

HC Wainwright Raises Price For This Lung Disease Stock On First Pivotal Readout

By Vandana Singh
August 29, 2:48 PM
Earlier this month, Verona Pharma plc (NASDAQ:VRNA) reported positive data from the ENHANCE-2 Phase 3 trial of ensifentrine, the company’s lead drug…

VRNA

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Price Target
  • Reiteration
  • Trading Ideas

HC Wainwright Bullish On This Small Cap Stock As Enrollment Starts In Pivotal Skin Disease Trial

By Vandana Singh
August 29, 2:33 PM
Earlier this month, Timber Pharmaceuticals Inc (NYSE:TMBR) reported that the first four patients had been enrolled in the Phase 3 ASCEND study…

TMBR

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Tech

Needham Remains Bullish On Ciena Ahead Of Its Quarterly Results As Supply Appears To Be Improving

By Anusuya Lahiri
August 29, 1:59 PM
Ciena Corp (NYSE: CIEN) reports quarterly results on September 1 before the market opens.  Needham analyst Alex Henderson expects another supply-constrained quarter, with Orders above Shipments and Revenues modestly ahead of forecast. 

CIEN

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Small Cap
  • Tech

The ‘Trough’ In Video Processing Is Over. Ambarella Will Drive Revenue From Here, Analyst Says Ahead of Earnings

By Anusuya Lahiri
August 29, 1:43 PM
Rosenblatt analyst Kevin Cassidy sees Ambarella, Inc's (NASDAQ: AMBA) July quarter as the trough due to a perfect storm of events hitting their business.

AMBA

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Tech

Marvell Technology’s Macro, Inflation Headwinds Prompt 5% Price Target Cut By Citi

By Anusuya Lahiri
August 29, 12:53 PM
Citi analysts Atif Malik and Amanda Scarnati reiterated a Buy on Marvell Technology, Inc (NASDAQ:MRVL) but reduced the price target from $78 to…

AMD

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Tech

Alibaba Has 63% Upside And Room For Margin Expansion, Bullish Analyst Says

By Anusuya Lahiri
August 29, 12:27 PM
Mizuho analyst James Lee reiterated a Buy on Alibaba Group Holding Limited (NYSE:BABA) with a $160 price target. The re-rating followed an investor…

BABA

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Tech

Okta Analyst Knocks Off Price Target By 13%, Courtesy Microsoft

By Anusuya Lahiri
August 29, 12:13 PM
BMO Capital analyst Keith Bachman maintained Okta Inc (NASDAQ:OKTA) with an Outperform and lowered the price target from $125 to $110 ahead of…

MSFT

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • Movers
  • News
  • Price Target
  • Reiteration
  • Tech
  • Trading Ideas

3 Dell Technologies Analysts Offer Different Takes On Mixed Results

By Priya Nigam
August 26, 3:23 PM
Dell Technologies Inc (NYSE: DELL) reported on Thursday mixed results for its second quarter, with an earnings beat but revenue short of Wall Street expectations. Morgan Stanley On Dell Technologies

DELL

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration

Ulta Beauty Sees No Signs Of Trade-Down, Says This Analyst

By Shivani Kumaresan
August 26, 3:23 PM
Raymond James analyst Olivia Tong reiterated a Strong Buy rating on the shares of Ulta Beauty Inc (NASDAQ:ULTA) and raised the price target…

ULTA

Posts pagination

Previous 1 … 374 375 376 … 399 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service